In-Vitro Fertilization (IVF) Industry Global Overview: Market Size, Growth Insights and Forecast

Report ID : 1328831 | Published : February 2025 | Study Period : 2023-2033 | Format : PDF + Excel

The market size of the In-Vitro Fertilization (IVF) Industry is categorized based on Technology (Intracytoplasmic Sperm Injection (ICSI), Preimplantation Genetic Testing (PGT), Cryopreservation, Surgical Sperm Retrieval, Oocyte Preservation) and Procedure (Fresh IVF Cycle, Frozen IVF Cycle, Donor Egg IVF Cycle, Gestational Carrier IVF Cycle, IVF with Preimplantation Genetic Testing) and End User (Fertility Clinics, Hospitals, Clinical Research Institutes, Surgical Centers, Homecare Settings) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

The In-Vitro Fertilization (IVF) Industry, valued at $20.4 billion in 2023, is anticipated to expand to $35.7 billion by 2033 at a CAGR of 5.7% from 2024 to 2033. This report covers different segments and offers an analysis of the substantial trends and factors affecting the market.

In-Vitro Fertilization (IVF) as a marketplace has rapidly come to be an essential part of the healthcare system, providing the necessary services that individuals and couples struggling with infertility require. With the advancement in technologies surrounding reproduction, the need for IVF services has increased due to sociological factors, widespread awareness, and better success rates. This ‘new’ market is served by many types of stakeholders, including but not limited to, fertility clinics, pharmaceutical companies, and biotechnology companies which help provide innovative ways to help people conceive.

In the past few years, technological innovation, regulation updateas, and consumer preference shifts have completely altered this marketplace. These factors have created a competitive market where clinics try to outdo each other by providing personalized services and advanced treatments. The competition in the market is increasing with the focus now not only on the success rates of the procedures done, but on the overall support provided to patients through their entire fertility process. Supported by the rise in infertility rates, IVF becomes an essential focus in discussion for reproductive health and market research.

 

ATTRIBUTES	DETAILS
STUDY PERIOD	2023-2033
BASE YEAR	2023
FORECAST PERIOD	2024-2033
HISTORICAL PERIOD	2023-2024
UNIT	VALUE (USD BILLION)
KEY COMPANIES PROFILED	IVF Australia, CooperSurgical Inc., Merck KGaA, Ferring Pharmaceuticals, Bayer AG, Vitrolife AB, Cook Medical, Irvine Scientific, Reproductive Health Specialists, OvaScience Inc., Genea Limited
SEGMENTS COVERED	By Technology - Intracytoplasmic Sperm Injection (ICSI), Preimplantation Genetic Testing (PGT), Cryopreservation, Surgical Sperm Retrieval, Oocyte Preservation By Procedure - Fresh IVF Cycle, Frozen IVF Cycle, Donor Egg IVF Cycle, Gestational Carrier IVF Cycle, IVF with Preimplantation Genetic Testing By End User - Fertility Clinics, Hospitals, Clinical Research Institutes, Surgical Centers, Homecare Settings By Geography - North America, Europe, APAC, Middle East Asia & Rest of World.

---

In-Vitro Fertilization (IVF) Industry Dynamics

The In-Vitro Fertilization (IVF) Industry is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.

Market Drivers

1. Technological Advancements
2. Increasing Consumer Demand
3. Regulatory Support
4. Globalization

Market Restraints

1. High Operational Costs
2. Regulatory Challenges
3. Market Saturation

Market Opportunities

1. Emerging Markets
2. Product Innovation
3. Strategic Partnerships

Market Challenges

1. Technological Disruptions
2. Supply Chain Issues
3. Changing Consumer Preferences

---

Key Players in the In-Vitro Fertilization (IVF) Industry

This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.

• IVF Australia
• CooperSurgical Inc.
• Merck KGaA
• Ferring Pharmaceuticals
• Bayer AG
• Vitrolife AB
• Cook Medical
• Irvine Scientific
• Reproductive Health Specialists
• OvaScience Inc.
• Genea Limited

---

Customization Options

Verified Industry Insights offers one of the following report customization options to our respectable clients :

Company Profiling

● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)

Competitive Benchmarking

● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research

Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439

© 2024 Verified Industry Insights. All Rights Reserved